Skip to main content

and
  1. Article

    Open Access

    Safety Evaluation of Recombinant Fusion Protein RP22 as a Skin Test Reagent for Tuberculosis Diagnosis: A Phase I Clinical Trial

    This phase I clinical trial was conducted to evaluate the safety of RP22 as a skin test reagent for tuberculosis (TB) diagnosis and to explore the appropriate dosage.

    Lu **a, Xu-hui Liu, Zhang-yan Zhao, Tao Li, **u-hong ** in Infectious Diseases and Therapy (2021)

  2. Article

    Open Access

    Mannose-binding lectin 2 gene polymorphisms and their association with tuberculosis in a Chinese population

    Immune- and inflammation-related genes (IIRGs) play an important role in the pathogenesis of tuberculosis (TB). However, the relationship between IIRG polymorphisms and TB risk remains unknown. In this study, ...

    Jun-**an Zhang, Wen-** Gong, Dong-Lin Zhu, Hui-Ru An in Infectious Diseases of Poverty (2020)